£46.00

It has never been this cheap. We have no record of a lower price.

£46 today · cheaper than every other day in the last 3 months

Génétique moléculaire de la leucémie myéloïde aiguë à facteur de liaison central (Core Binding Factor)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 35 days · 35 data points (no recent data)

Historical
Generating forecast…
£46.00 £43.70 £44.62 £45.54 £46.46 £47.38 £48.30 11 August 2026 19 August 2026 28 August 2026 05 September 2026 14 September 2026
View at Amazon ↗

Price data last checked 56 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 35 days • 1 price levels

Days at Price
35 days 0 9 18 26 35 £46 Days at Price

Price Analysis

Most common price: £46 (35 days, 100.0%)

Price range: £46 - £46

Price levels: 1 different prices over 35 days

Description

Les dernières innovations en matière de biologie moléculaire, de génétique et de biologie cellulaire ont révolutionné la compréhension de la parthénogenèse des maladies et les efforts liés à la découverte de nouveaux biomarqueurs de maladies et de cibles médicamenteuses, conduisant finalement au développement de médicaments plus efficaces avec moins d'effets secondaires. Ces approches de pointe se sont concentrées sur la leucémie et d'autres cancers du sang, avec la découverte de nombreux nouveaux gènes cancérigènes et de thérapies ciblant directement les cellules cancéreuses et les oncogènes. La leucémie myéloïde aiguë (LMA) a fait l'objet d'innovations majeures en termes de diagnostic précoce, de sous-classification moléculaire de la maladie, de stratification pronostique et de découverte de nouveaux médicaments, pour aboutir à un traitement adapté aux besoins des patients atteints de LMA. Ce livre fournit un compte rendu de la biologie et de la base génétique de la LAM et de leur implication dans la clinique et la recherche.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
25 January 2022
Listed Since
27 January 2022

Barcode

No barcode data available

Similar Products You Might Like

Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)
82% match

Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)

Humana

£80.67 23 Oct 2026
Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)
82% match

Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)

Humana

£95.74 23 Oct 2026
Genetic Changes and Their Prognostic Impact In Leukaemia Patients: Characterization of Cytogenetic and Molecular Genetic Changes and Their Prognostic impact in Acute Leukaemia Patients
81% match

Genetic Changes and Their Prognostic Impact In Leukaemia Patients: Characterization of Cytogenetic and Molecular Genetic Changes and Their Prognostic impact in Acute Leukaemia Patients

LAP Lambert Academic Publishing

£61.00 07 Nov 2026
Childhood Acute Lymphoblastic Leukemia
81% match

Childhood Acute Lymphoblastic Leukemia

Springer

£92.00 24 Oct 2026
Chronic Myeloid Leukemia (Hematologic Malignancies)
81% match

Chronic Myeloid Leukemia (Hematologic Malignancies)

Springer

£109.97 23 Oct 2026
Leukemia - Incorporating Acute & Chronic ALL, AML, CLL & CML
81% match

Leukemia - Incorporating Acute & Chronic ALL, AML, CLL & CML

CREATESPACE

£45.99 22 Oct 2026
Handbook of Leukemia
81% match

Handbook of Leukemia

Hayle Medical

£78.42 24 Oct 2026
Biologic Therapy of Leukemia (Contemporary Hematology)
80% match

Biologic Therapy of Leukemia (Contemporary Hematology)

Humana

£73.35 04 Nov 2026
Advances in the Treatment of B-Cell Chronic Lymphocytic Leukemia
80% match

Advances in the Treatment of B-Cell Chronic Lymphocytic Leukemia

£60.00 30 Oct 2026
Myelodysplastic Syndromes: Diagnosis - Prognosis - Therapy (Hematologic Malignancies)
80% match

Myelodysplastic Syndromes: Diagnosis - Prognosis - Therapy (Hematologic Malignancies)

Springer

£73.14 17 Oct 2026
Chronic Myeloproliferative Disorders
80% match

Chronic Myeloproliferative Disorders

CRC Press

£134.97 24 Oct 2026
Advances in Hematopoietic Stem Cell Transplantation and Molecular Therapy: 144 (Recent Results in Cancer Research, 144)
80% match

Advances in Hematopoietic Stem Cell Transplantation and Molecular Therapy: 144 (Recent Results in Cancer Research, 144)

Springer

£78.01 14 Sep 2026
Diagnosis of Blood and Bone Marrow Disorders
80% match

Diagnosis of Blood and Bone Marrow Disorders

Springer

£65.49 20 Oct 2026
Diagnosis of Blood and Bone Marrow Disorders
80% match

Diagnosis of Blood and Bone Marrow Disorders

Springer

£89.28 22 Oct 2026
Invasive Mykosen bei Patienten mit akuter myeloischer Leukämie: Inzidenz, Letalität und Analyse der Diagnosekriterien der European Organization for Research and Treatment of Cancer
79% match

Invasive Mykosen bei Patienten mit akuter myeloischer Leukämie: Inzidenz, Letalität und Analyse der Diagnosekriterien der European Organization for Research and Treatment of Cancer

£45.00 05 Sep 2026
New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia
79% match

New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia

Springer

£81.12 15 Sep 2026
Multiple Myeloma - a New Era of Treatment Strategies
79% match

Multiple Myeloma - a New Era of Treatment Strategies

£85.29 27 Oct 2026
Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies
79% match

Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies

Springer

£84.64 23 Oct 2026
Chronic Lymphocytic Leukemia: New Research
78% match

Chronic Lymphocytic Leukemia: New Research

£109.99 15 Sep 2026
Non-Neoplastic Hematologic Disorders: A Quick Review of Modern Diagnostic and Therapeutic Approaches
78% match

Non-Neoplastic Hematologic Disorders: A Quick Review of Modern Diagnostic and Therapeutic Approaches

Springer

£103.27 20 Oct 2026
Lymphoma: Pathology, Diagnosis and Treatment
78% match

Lymphoma: Pathology, Diagnosis and Treatment

Cambridge University Press

£73.70 21 Oct 2026
Molecular Basis of Chronic Myeloproliferative Disorders
78% match

Molecular Basis of Chronic Myeloproliferative Disorders

Springer

£78.01 26 Oct 2026
Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)
78% match

Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)

Springer

£76.42 24 Oct 2026
Advances in Biology and Therapy of Multiple Myeloma: Volume 1: Basic Science
78% match

Advances in Biology and Therapy of Multiple Myeloma: Volume 1: Basic Science

Springer

£112.02 24 Oct 2026